A preliminary study on the neurotoxic mechanism of harmine in Caenorhabditis elegans

Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
2021.0

Abstract

Harmine is a beta-carboline and harmala alkaloid with extensive bioactivities. However, its toxicity, especially in neural system, is not systematically assessed and the toxic mechanism is not yet clear. Using Caenorhabditis elegans (C. elegans) as a model system, we found that harmine exhibited dosage dependent (0, 5, 10, 20, 40, 80, 160, and 320 mu mol/L) toxic effect, such as growth inhibition, egg laying defects, shortened life span and increased mortality. Although harmine did not result in obvious structural alterations in neurite or death of neurons, it did show direct acetylcholinesterase inhibition activity. Further, we found that harmine treatment decreased worm pharyngeal pump rate and lowered the content of nitric oxide (NO) in worm body, implying foraging disorders, which is an indicator of acetylcholinergic neuron activity inhibition. Besides, network pharmacology and molecular docking reveals that acetylcholinesterase is one of the major neural toxicity targets as well. Above all, harmine can directly inhibit the activity of acetylcholinesterase, leading to excessive accumulation of acetylcholine, which may be one of the harmine neurotoxicity mechanisms.

Knowledge Graph

Similar Paper

A preliminary study on the neurotoxic mechanism of harmine in Caenorhabditis elegans
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021.0
β-Carbolines norharman and harman change neurobehavior causing neurological damage inCaenorhabditis elegans
Food & Function 2023.0
Antitumor and neurotoxic effects of novel harmine derivatives and structure‐activity relationship analysis
International Journal of Cancer 2005.0
Synthesis and structure–activity relationships of harmine derivatives as potential antitumor agents
European Journal of Medicinal Chemistry 2013.0
Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
Journal of Enzyme Inhibition and Medicinal Chemistry 2023.0
Pharmacological effects of harmine and its derivatives: a review
Archives of Pharmacal Research 2020.0
Harmine Inhibits Multiple TLR-Induced Inflammatory Expression through Modulation of NF-κB p65, JNK, and STAT1
Life 2022.0
Harmaline toxicity on dorsal striatal neurons and its role in tremor
NeuroToxicology 2023.0
Acetylcholinesterase inhibitive activity-guided isolation of two new alkaloids from seeds of Peganum nigellastrum Bunge by an in vitro TLC- bioautographic assay
Archives of Pharmacal Research 2009.0
Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease
European Journal of Medicinal Chemistry 2022.0